Patents Examined by Tammie K Marlen
  • Patent number: 11179570
    Abstract: In at least one example, a medical device is provided. The medical device includes at least one therapy electrode, at least one acoustic sensor, and at least one processor coupled with the at least one therapy electrode and the at least one acoustic sensor. The at least one processor is configured to deliver at least one pacing pulse via the at least one therapy electrode and to analyze processed acoustic data to determine whether the at least one pacing pulse resulted in capture.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: November 23, 2021
    Assignee: ZOLL Medical Corporation
    Inventors: Shane S. Volpe, Gregory R. Frank, Thomas E. Kaib, Steven J. Szymkiewicz, Gary A. Freeman
  • Patent number: 11179574
    Abstract: A method of administering 5-aminolevulinic acid (ALA) to a patient uses an adjustable illuminator for photodynamically diagnosing or treating a surface and which includes a plurality of first panels and at least one second panel. The plurality of first panels have wider widths and the at least one second panel has a narrower width. The narrower width is less than the wider widths. The illuminator further includes a plurality of light sources, each mounted to one of the plurality of first panels or the at least one second panel and configured to irradiate the surface with substantially uniform intensity visible light. The plurality of first panels and the at least one second panel are rotatably connected. The at least one second panel is connected on each side to one of the plurality of first panels. The second panel acts as a “lighted hinge” to reduce or eliminate optical dead spaces between adjacent panels when the illuminator is bent into a certain configuration.
    Type: Grant
    Filed: September 2, 2020
    Date of Patent: November 23, 2021
    Assignee: DUSA PHARMACEUTICALS, INC.
    Inventors: Thomas Boyajian, Mark Carota, Brian Mazejka
  • Patent number: 11173301
    Abstract: A method for assisting respiration by electrical stimulation includes: acquiring a time parameter of a target respiratory process; and outputting a phrenic nerve stimulating signal to a diaphragm stimulating electrode within a time period corresponding to inspiration and outputting an abdominal muscle stimulating signal to an abdominal muscle stimulating electrode within a time period corresponding to expiration, according to the time parameter of the target respiratory process.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: November 16, 2021
    Assignee: YAGUO INC.
    Inventor: Xiaoqi Cai
  • Patent number: 11154709
    Abstract: Delivery of peripheral nerve field stimulation (PNFS) in combination with one or more other therapies is described. The other therapy delivered in combination with PNFS may be, for example, a different type of neurostimulation, such as spinal cord stimulation (SCS), or a drug. PNFS and the other therapy may be delivered simultaneously, in an alternating fashion, according to a schedule, and/or selectively, e.g., in response to a request received from a patient or clinician. A combination therapy that includes PNFS may be able to more completely address complex or multifocal pain than would be possible through delivery of either PNFS or other therapies alone. Further, the combination of PNFS with one or more other therapies may reduce the likelihood that neural accommodation will impair the perceived effectiveness PNFS or the other therapies.
    Type: Grant
    Filed: April 8, 2019
    Date of Patent: October 26, 2021
    Assignee: Medtronic, Inc.
    Inventors: Ethan A. Rooney, Carl D. Wahlstrand, Gary W. King, Thomas E. Cross, Jr., Kenneth T. Heruth, Paul W. Wacnik, Jeffrey S. Evanson
  • Patent number: 11129985
    Abstract: Generally discussed herein are systems, devices, and methods for providing a therapy (e.g., stimulation) and/or data signal using an implantable device. Systems, devices and methods for interacting with (e.g., communicating with, receiving power from) an external device are also provided.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: September 28, 2021
    Assignee: NEUSPERA MEDICAL, INC.
    Inventors: Timothy A. Fayram, Alexander Yeh, Gary Shaw, Randolph Kerry Armstrong, Milton M. Morris, Elia Junco
  • Patent number: 11123168
    Abstract: An electrical discharge irrigation includes a power source to produce a first voltage, a circuit coupled to the power source to convert the first voltage to a second voltage, a discharge capacitor to receive the second voltage from the circuit, a transistor and/or a controlled rectifier coupled to the discharge capacitor to receive the second voltage, and an output tip. This tip is coupled to a transistor and/or a controlled rectifier and includes a first end, a second end, a longitudinal axis extending between them, an electrode located in an interior space of the tip to receive an electrical charge from the a transistor and/or a controlled rectifier and to release an electric discharge, and a ground return. The ground return is an outside surface of the tip. A space between the electrode and the ground return holds a conductive medium in contact with the electrode and the ground return.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: September 21, 2021
    Assignee: G & H Technologies, LLC
    Inventors: Gilbert Fregoso, Brad Heckerman, Yuval Charles Avniel
  • Patent number: 11123540
    Abstract: In a catheter (2) to assist the performance of a heart (1) with at least one pump (7), the pump is formed as a rotary pump at the distal end of the catheter (2), the rotor (6) lying distally on the outer side being coupled via a magneto coupling with a drive wheel (21), formed as a hydraulically or pneumatically operated paddle wheel, arranged inside the catheter (2). The driving fluid is supplied to the paddle wheel via a lumen (22) of the catheter (2) and is carried off via a further lumen (23) of the catheter.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: September 21, 2021
    Assignee: Miracor Medical SA
    Inventor: Werner Mohl
  • Patent number: 11116439
    Abstract: Systems and methods for detecting slow and persistent rhythms, such as indicative of ventricular response to atrial tachyarrhythmia (AT), are described herein. An arrhythmia detection system monitors patient ventricular heart rate, and identifies slow heart beats with corresponding heart rates falling below a rate threshold during a detection period. The system identifies one or more sustained slow beat (SSB) sequences each including two or more slow heart beats. The system determines a first prevalence indicator of the identified slow heart beats, and a second prevalence indicator of the identified SSB sequences during the detection period. An arrhythmia detector circuit detects a slow and persistent rhythm using the first and second prevalence indicators.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: September 14, 2021
    Assignee: Cardiac Pacemakers, Inc.
    Inventors: David L. Perschbacher, Sunipa Saha, Deepa Mahajan
  • Patent number: 11103718
    Abstract: The present invention relates to a device, and software and methodology associated with a portable Automated External Defibrillator (“AED”). The portable AED works with a mobile device and software, and includes two or more cardiac pads, a battery pack, and specialized capacitor. When connected to a patient in cardiac arrest, the AED contacts Emergency Medical Services, and records patient information to be transmitted for evaluation by medical providers. The AED is able to analyze cardiac rhythms, suggests administering one or more shocks to the patient in appropriate cardiac arrhythmia, and guides a user on proper CPR technique, if enabled. The AED software can alert other personnel via a mobile device app.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: August 31, 2021
    Assignee: HeartHero, Inc.
    Inventors: Gary Montague, David Jon Farrell, James Dotter, Krista Grandey, James A. Gilbert, Neil D. Blank
  • Patent number: 11097121
    Abstract: Several defibrillators, defibrillator architectures, defibrillator components and methods of operating defibrillators are described. In one aspect, a modular defibrillator architecture is described. A base unit provides a fully functional defibrillator. The functionality of the base unit can be supplemented by attaching an interface unit to the base unit or by connecting a smartphone the base unit. Such devices provide connectivity as well as a screen for displaying supplementary graphics and/or videos which are useful to support both emergency and maintenance & monitoring activities. In some embodiments a battery pack may also or alternatively be coupled to the base unit to prolong the unit's shelf life before recharging or replacement of its batteries is required. If necessary the base unit can be powered from a connected external device such as a mobile communication device.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: August 24, 2021
    Assignee: Avive Solutions, Inc.
    Inventors: Rory M. Beyer, Gordon Moseley P. Andrews
  • Patent number: 11076795
    Abstract: A defibrillator (AED) using an ECG analysis model or algorithm which can function in two different modes. The ECG analysis model is particularly suited for analysis during periods of CPR. Both modes of operation reach a shock decision in essentially the same way, where one or more ECG data segments indicate a shockable cardiac condition. In one mode of operation, the shock decision is irreversible once made. In another mode of operation, the shock decision is reversible if one or more subsequent ECG data segments indicate a no-shock decision. Improved specificity of the model is obtained without undue degradation of sensitivity to shockable ECG.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: August 3, 2021
    Assignee: Koninklijke Philips N.V.
    Inventors: Chenguang Liu, Stacy Earl Gehman
  • Patent number: 11077311
    Abstract: Several defibrillators, defibrillator architectures, defibrillator components and methods of operating defibrillators are described. In one aspect, a modular defibrillator architecture is described. A base unit provides a fully functional defibrillator. The functionality of the base unit can be supplemented by attaching an interface unit to the base unit or by connecting a smartphone the base unit. Such devices provide connectivity as well as a screen for displaying supplementary graphics and/or videos which are useful to support both emergency and maintenance & monitoring activities. In some embodiments a battery pack may also or alternatively be coupled to the base unit to prolong the unit's shelf life before recharging or replacement of its batteries is required. If necessary the base unit can be powered from a connected external device such as a mobile communication device.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: August 3, 2021
    Assignee: AVIVE SOLUTIONS, INC.
    Inventors: Rory M. Beyer, Gordon Moseley P. Andrews
  • Patent number: 11058878
    Abstract: A urination disorder treatment device includes a pair of body-surface electrode pads to supply an electrical stimulation signal from a back of a sacral bone, a stimulation signal control output circuit from which the pair of body-surface electrode pads supply the stimulation signal, a first measurement portion to measure electrocardiographic data based on a signal of electrical activity of the heart of the person to be treated, and a control portion to control supply of the stimulation signal based on an electrocardiographic waveform measured by the first measurement portion. A heart rate of the person to be treated may be judged to be a normal value from the electrocardiographic data, the control portion may delay timing of an output pulse from the pair of body-surface electrode pads so as not to be synchronized with the atrial systole P or the ventricular systole R of the electrocardiographic waveform.
    Type: Grant
    Filed: July 2, 2018
    Date of Patent: July 13, 2021
    Assignee: OTSUKA TECHNO CORPORATION
    Inventors: Tetsuya Masuda, Nobuo Tsukui
  • Patent number: 11051905
    Abstract: Connector enclosure assemblies for medical devices provide an angled lead passageway. The lead passageway which is defined by electrical connectors and intervening seals within the connector enclosure assembly establishes the angle relative to a base plane of the connector enclosure assembly. Various other aspects may be included in conjunction with the angled lead passageway, including an angled housing of the connector enclosure assembly, feedthrough pins that extend to the electrical connectors where the feedthrough pins may include angled sections, and a set screw passageway set at an angle relative to the lead passageway to provide fixation of a lead within the lead passageway.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: July 6, 2021
    Assignee: MEDTRONIC, INC.
    Inventors: Steven T. Deininger, Michael J. Baade, Charles E. Peters
  • Patent number: 11052261
    Abstract: The present invention provides both methods and devices for termination of arrhythmias, such as ventricular or atrial tachyarrhythmias. The device and method involves application of alternating current (AC) for clinically significant durations at selected therapeutic frequencies through the cardiac tissue to a subject experiencing arrhythmia. Methods are also provided to minimize or eliminate pain during defibrillation.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: July 6, 2021
    Assignee: The Johns Hopkins University
    Inventors: Harikrishna Tandri, Ronald David Berger, Seth Weinberg, Leslie Tung, Henry Halperin, David Hunter
  • Patent number: 11045650
    Abstract: In general, techniques, methods, systems, and devices for delivering high frequency neurostimulation to control one or more pelvic disorders are described. In one example, a method includes identifying, by a medical device configured to be at least partially implanted in a patient, an indication to inhibit bladder activity. The medical device generates, in response to identifying the indication, electrical stimulation therapy comprising first electrical stimulation pulses comprising a first frequency greater than or equal to about 500 Hertz and less than or equal to about 5,000 Hertz. Further, the medical device delivers the electrical stimulation therapy to a target nerve selected from a group consisting of: a sacral nerve, a pelvic nerve, a tibial nerve, and a pudendal nerve of the patient.
    Type: Grant
    Filed: December 5, 2017
    Date of Patent: June 29, 2021
    Assignee: Medtronic, Inc.
    Inventors: Thaddeus S. Brink, Dwight E. Nelson, Lance Zirpel, Xin Su, Blake A. Hedstrom, Erik J. Peterson, David A. Dinsmoor
  • Patent number: 11027120
    Abstract: An apparatus for the treatment of urinary incontinence includes a balloon configured for movement between an inflated state and a deflated state, and the balloon includes bellows. An electrode is coupled to an outer surface of the balloon, and is configured to transmit an electrical pulse to cause a contraction of a muscle in communication with the electrode. A control device is configured to be operable by a user to cause the balloon to selectively move between the inflated state and the deflated state and to cause the electrode to transmit the electrical pulse. The bellows and the electrode are configured to cooperate to maintain the structural integrity of the balloon. The bellows and the electrode are further configured to cooperate to cause the balloon to inflate in a radially non-uniform manner.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: June 8, 2021
    Assignee: InControl Medical, LLC
    Inventor: Herschel Peddicord
  • Patent number: 11020588
    Abstract: The present invention provides advancements in the art of cardiac pacemakers. The invention provides a pacemaker system that comprises at least one pacemaker and that is, to a large extent, self-controlled, allows for long-term implantation in a patient, and minimizes current inconveniences and problems associated with battery life. The invention further includes a mechanism in which at least two pacemakers are implanted in a patient, and in which the pacemakers communicate with each other at the time of a given pacing or respiratory event, without any required external input, and adjust pacing parameters to respond to the patient's need for blood flow. The invention further provides a design for a pacemaker in which the pacemaker electrode is connected to the pacemaker body by a lead that is configured to allow the pacemaker to lie parallel to the epicardial surface and to reduce stress on the pacemaker and heart tissue.
    Type: Grant
    Filed: May 8, 2014
    Date of Patent: June 1, 2021
    Assignees: CHILDREN'S HOSPITAL LOS ANGELES, UNIVERSITY OF SOUTHERN CALIFORNIA
    Inventors: Yaniv Bar-Cohen, Gerald Loeb, Li Zhou, Raymond Peck, Steven Nutt
  • Patent number: 11020002
    Abstract: Some embodiments of the current disclosure are directed toward physiological monitoring of patients, and more particularly, systems, devices and methods for physiological monitoring of patients with a continuous or near-continuous transmission and analysis of monitored physiological data during the monitoring process. In some embodiments, a physiological patient monitoring system is provided which includes a physiological monitoring device which comprises a housing disposed on a patch, and the patch is configured for removable attachment to or proximate the skin of a patient, the housing including at least one memory. Antenna disposed on the housing transmit radio-frequency (RF) waves towards a targeted portion of an internal tissue of the patient and receive reflected RF waves from the internal tissue. RF circuitry in communication with the at least one memory perform an RF-based measurement of a lung fluid level of the patient during a predetermined time period.
    Type: Grant
    Filed: July 20, 2018
    Date of Patent: June 1, 2021
    Assignee: ZOLL MEDICAL ISRAEL LTD.
    Inventors: Uriel Weinstein, Rafi Ravid, David Meshulam, Roman Vaistikh, Leonid Bekman, Noa Graf, Ronen Eldar, Daniel Quartler, Arkadi Averbuch, Vered Cohen Sharvit
  • Patent number: 10994140
    Abstract: Generally discussed herein are systems, devices, and methods for providing a therapy (e.g., stimulation) and/or data signal using an implantable device. Systems, devices and methods for interacting with (e.g., communicating with, receiving power from) an external device are also provided. A system can include an external power source that propagates a field within tissue and an at least partially implantable device configured to receive the propagated field from the external power source, the implantable device including circuitry, a first antenna electrically coupled to the circuitry, a second antenna electrically coupled to the first antenna, and an electrode electrically connected to the circuitry.
    Type: Grant
    Filed: April 29, 2019
    Date of Patent: May 4, 2021
    Assignee: NEUSPERA MEDICAL INC.
    Inventors: Alexander Yeh, Elia Junco